Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan-Amoxicillin Dual Therapy vs Bismuth Quadruple Therapy for H. Pylori Eradication
NCT05647278Phase 4Completed
- Start
- Nov 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegoprazan in Helicobacter pylori infection (3 arms). Primary endpoint: Percentage of Helicobacter Pylori Positive (HP+) Participants With Successful HP Eradication. Started Nov 2023; status: completed.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05647278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05647278.